Meeting
2018 Genitourinary Cancers Symposium
Improved survival rates in kidney cancer patients with brain metastases treated with modern multidisciplinary approaches.
Authors
I. Alex Bowman
UT Southwestern Medical Center, Dallas, TX
I. Alex Bowman , Alisha Bent , Tri Le , Alana Christie , Zabi Wardak , Bruce Mickey , Robert D. Timmerman , Raquibul Hannan , James Brugarolas
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Renal Cell Cancer
Track
Renal Cell Cancer
Sub Track
Renal Cell Cancer
Citation
J Clin Oncol 36, 2018 (suppl 6S; abstr 601)
DOI
10.1200/JCO.2018.36.6_suppl.601
Abstract #
601
Poster Bd #
F16
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Annual Meeting
Treatment outcomes of brain metastasis from primary renal cell carcinoma in United States: A National Cancer Database analysis.
First Author: Vivek Podder
Poster
2022 ASCO Genitourinary Cancers Symposium
Characteristics and outcomes of patients managed with surgical resection of brain metastasis from renal cell carcinoma.
First Author: Max Drescher
Poster
2022 ASCO Genitourinary Cancers Symposium
The role of cytoreductive nephrectomy and systemic therapy in the management of tumor thrombus in patients with metastatic renal cell carcinoma.
First Author: Abhenil Mittal
Poster
2022 ASCO Genitourinary Cancers Symposium
Active surveillance in metastatic renal cell carcinoma: A single-center cohort.
First Author: William Schwartzman